**Core Concept**
The use of four drugs in the treatment of tuberculosis (TB) as per the Anti-Tuberculosis Therapy (AKT) regimen is a strategic approach to combat the development of drug resistance. TB bacteria can rapidly develop resistance to a single antibiotic, making it essential to use a combination of drugs to delay or prevent the emergence of resistant strains.

**Why the Correct Answer is Right**
The four-drug regimen used in AKT includes isoniazid, rifampicin, pyrazinamide, and ethambutol. The primary reason for using this combination is to decrease the likelihood of resistance by mutation. Isoniazid and rifampicin are potent bactericidal agents that target different aspects of TB bacteria's metabolism, making it less likely for the bacteria to develop resistance to both drugs simultaneously. This combination also includes pyrazinamide, which is effective against TB bacteria in acidic environments, and ethambutol, which inhibits the synthesis of the bacterial cell wall. By using a combination of drugs, the AKT regimen reduces the selective pressure for resistance to develop, allowing for more effective treatment and reducing the risk of treatment failure.

**Why Each Wrong Option is Incorrect**
**Option B:** Conjugation is a mechanism of horizontal gene transfer that allows bacteria to share genetic material, but it is not the primary reason for using the four-drug AKT regimen. While conjugation can contribute to the spread of antibiotic resistance, it is not a factor in the choice of drugs used in AKT.

**Option C:** The primary goal of AKT is not to cure the disease early but to effectively treat TB and prevent the development of drug resistance. While early cure is an important outcome, it is not the primary reason for using a four-drug regimen.

**Option D:** This option is incorrect because the four-drug AKT regimen is specifically designed to decrease resistance by mutation.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that the use of a combination of drugs in TB treatment is a critical strategy to prevent the emergence of drug-resistant strains. This approach is not unique to TB and is used in the treatment of other bacterial infections as well, such as HIV and malaria.

**✓ Correct Answer: A. Decrease in resistance by mutation**